New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
07:39 EDTMDASMedAssets pullback a buying opportunity, says Jefferies
Jefferies believes MedAssets' core business is back on track following yesterday's analyst day and it recommends buying the stock on the recent pullback. The firm has a Buy rating on the name with a $30 price target.
News For MDAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2016
10:31 EDTMDASPamplona Capital completes acquisition of MedAssets
Pamplona Capital Management has completed the acquisition of MedAssets. As a result of the transaction, MedAssets stock will stop trading at the close of business today. Pamplona purchased MedAssets for $31.35 per share, which represents a total enterprise value of approximately $2.7B. The transaction was overwhelmingly approved by stockholders on January 14, with 99.8% of total votes cast in favor. Separately, Pamplona has entered into an agreement with Vizient to divest MedAssets' Spend and Clinical Resource Management segment to Vizient. That transaction is expected to be completed in mid-February 2016.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use